Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines ›Takeda Pharmaceuticals International AG Ireland Branch
Medicines register · Ireland

Takeda Pharmaceuticals International AG Ireland Branch — licensed medicines

40 medicines held by Takeda Pharmaceuticals International AG Ireland Branch on the Irish market, from the HPRA register.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 08 Oct 2026, 03:31 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
40 of 10,296 medicines
Download
Medicine
Active substance
Licence holder
Status
Elaprase 2 mg/ml concentrate for solution for infusion EU/1/06/365/1-3
Idursulfase
Takeda Pharmaceuticals International AG Ireland Branch
—
Equasym XL 10 mg modified-release capsules, hard PA23211/001/001
Methylphenidate hydrochloride
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Equasym XL 20 mg modified-release capsules, hard PA23211/001/002
Methylphenidate hydrochloride
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Equasym XL 30 mg modified-release capsules, hard PA23211/001/003
Methylphenidate hydrochloride
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Equasym XL 40 mg modified-release capsules, hard PA23211/001/004
Methylphenidate hydrochloride
Takeda Pharmaceuticals International AG Ireland Branch
Not marketed
Equasym XL 50 mg modified-release capsules, hard PA23211/001/005
Methylphenidate hydrochloride
Takeda Pharmaceuticals International AG Ireland Branch
Not marketed
Equasym XL 60 mg modified-release capsules, hard PA23211/001/006
Methylphenidate hydrochloride
Takeda Pharmaceuticals International AG Ireland Branch
Not marketed
Firazyr 30 mg solution for injection in pre-filled syringe EU/1/08/461/001-002
Icatibant
Takeda Pharmaceuticals International AG Ireland Branch
—
Foznol 1000 mg Chewable Tablets PA23211/002/004
Lanthanum
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Foznol 1000 mg Oral Powder PA23211/002/006
Lanthanum carbonate hydrate
Takeda Pharmaceuticals International AG Ireland Branch
Not marketed
Foznol 250 mg Chewable Tablets PA23211/002/001
Lanthanum carbonate hydrate
Takeda Pharmaceuticals International AG Ireland Branch
Not marketed
Foznol 500 mg Chewable Tablets PA23211/002/002
Lanthanum
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Foznol 750 mg Chewable Tablets PA23211/002/003
Lanthanum
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Foznol 750 mg Oral Powder PA23211/002/005
Lanthanum carbonate hydrate
Takeda Pharmaceuticals International AG Ireland Branch
Not marketed
Intuniv 1 mg prolonged-release tablets EU/1/15/1040/001-002
GUANFACINE HYDROCHLORIDE
Takeda Pharmaceuticals International AG Ireland Branch
—
Intuniv 2 mg prolonged-release tablets EU/1/15/1040/003-005
GUANFACINE HYDROCHLORIDE
Takeda Pharmaceuticals International AG Ireland Branch
—
Intuniv 3 mg prolonged-release tablets EU/1/15/1040/006-007
GUANFACINE HYDROCHLORIDE
Takeda Pharmaceuticals International AG Ireland Branch
—
Intuniv 4 mg prolonged-release tablets EU/1/15/1040/008-009
GUANFACINE HYDROCHLORIDE
Takeda Pharmaceuticals International AG Ireland Branch
—
LIVTENCITY 200 mg film-coated tablets EU/1/22/1672/001-002
Maribavir
Takeda Pharmaceuticals International AG Ireland Branch
—
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets PA23211/004/001
Mesalazine
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Plenadren 20 mg modified-release tablets EU/1/11/715/002
Hydrocortisone
Takeda Pharmaceuticals International AG Ireland Branch
—
Plenadren 5 mg modified-release tablets EU/1/11/715/001
Hydrocortisone
Takeda Pharmaceuticals International AG Ireland Branch
—
Qdenga powder and solvent for solution for injection EU/1/22/1699/001
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
Takeda Pharmaceuticals International AG Ireland Branch
—
Qdenga powder and solvent for solution for injection EU/1/22/1699/002
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
Takeda Pharmaceuticals International AG Ireland Branch
—
Qdenga powder and solvent for solution for injection EU/1/22/1699/003
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
Takeda Pharmaceuticals International AG Ireland Branch
—
Qdenga powder and solvent for solution for injection EU/1/22/1699/004
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
Takeda Pharmaceuticals International AG Ireland Branch
—
Replagal 1 mg/ml concentrate for solution for infusion EU/1/01/189/001
Agalsidase alfa
Takeda Pharmaceuticals International AG Ireland Branch
—
Resolor 1 mg film-coated tablets EU/1/09/581/001
Prucalopride Succinate
Takeda Pharmaceuticals International AG Ireland Branch
—
Resolor 2 mg film-coated tablets EU/1/09/581/002
Prucalopride Succinate
Takeda Pharmaceuticals International AG Ireland Branch
—
Revestive 1.25 mg powder and solvent for solution for injection EU/1/12/787/003
Teduglutide
Takeda Pharmaceuticals International AG Ireland Branch
—
Revestive 5 mg powder and solvent for solution for injection EU/1/12/787/001
Teduglutide
Takeda Pharmaceuticals International AG Ireland Branch
—
TAKHZYRO 150 mg solution for injection in pre-filled syringe EU/1/18/1340/007-009
LANADELUMAB
Takeda Pharmaceuticals International AG Ireland Branch
—
TAKHZYRO 300 mg solution for injection EU/1/18/1340/001
LANADELUMAB
Takeda Pharmaceuticals International AG Ireland Branch
—
Tyvense 20 mg capsules, hard PA23211/005/001
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 30 mg capsules, hard PA23211/005/002
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 40 mg capsules, hard PA23211/005/003
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 50 mg capsules, hard PA23211/005/004
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 60 mg capsules, hard PA23211/005/005
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Tyvense 70 mg capsules, hard PA23211/005/006
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch
Marketed
Xagrid 0.5 mg hard capsules EU/1/04/295/001
Anagrelide hydrochloride
Takeda Pharmaceuticals International AG Ireland Branch
—
Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 8 October 2026. https://priyalifescience.com/medicines/company/takeda-pharmaceuticals-international-ag-ireland-branch

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.